MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Avita Therapeutics Inc

Gesloten

3.25 -0.91

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.21

Max

3.35

Belangrijke statistieken

By Trading Economics

Inkomsten

-3.3M

-13M

Verkoop

-1.4M

17M

Winstmarge

-77.289

Werknemers

260

EBITDA

-3.2M

-11M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+29.18% upside

Dividenden

By Dow Jones

Volgende Winsten

12 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-15M

106M

Vorige openingsprijs

4.16

Vorige sluitingsprijs

3.25

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 jan 2026, 23:08 UTC

Acquisities, Fusies, Overnames

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 jan 2026, 21:39 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 jan 2026, 20:54 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Restart Merger Talks -- Update

8 jan 2026, 20:44 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Restart Merger Talks

8 jan 2026, 17:05 UTC

Acquisities, Fusies, Overnames

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 jan 2026, 16:43 UTC

Belangrijke Marktbewegers

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 jan 2026, 23:44 UTC

Marktinformatie

Nikkei May Rise on Weaker Yen -- Market Talk

8 jan 2026, 23:37 UTC

Marktinformatie

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 jan 2026, 22:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

8 jan 2026, 22:42 UTC

Marktinformatie

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 jan 2026, 22:30 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 jan 2026, 21:53 UTC

Winsten

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

8 jan 2026, 21:10 UTC

Acquisities, Fusies, Overnames

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 jan 2026, 21:09 UTC

Marktinformatie

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 jan 2026, 21:09 UTC

Acquisities, Fusies, Overnames

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 jan 2026, 20:21 UTC

Marktinformatie

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 jan 2026, 19:44 UTC

Marktinformatie

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 jan 2026, 18:50 UTC

Marktinformatie

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 jan 2026, 17:48 UTC

Winsten

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 jan 2026, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 jan 2026, 17:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

8 jan 2026, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

8 jan 2026, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

8 jan 2026, 16:45 UTC

Marktinformatie

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 jan 2026, 16:03 UTC

Marktinformatie

Global Equities Roundup: Market Talk

8 jan 2026, 16:03 UTC

Marktinformatie

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 jan 2026, 16:02 UTC

Marktinformatie

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 jan 2026, 15:23 UTC

Acquisities, Fusies, Overnames

Paramount Defends Its Hostile Bid for Warner -- Update

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

29.18% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.25 USD  29.18%

Hoogste 5.5 USD

Laagste 3 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat